Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP

 SummaryQuotesNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
Latest news on CHELSEA THERAPEUTICS INTER
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
2014 CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investi..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 CHELSEA THERAPEUTICS : Newman Ferrara LLP : Announces Investigation of Chelsea T..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brower Piven Announces the Investigati..
2014 CHELSEA THERAPEUTICS : Law Firm Kirby McInerney LLP Investigating Potential Clai..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inves..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
More news
Sector news : Bio Therapeutic Drugs
05:01p China's Creat makes 1.2 billion euro bid for German blood plasma firm
03/28DJREGENERON PHARMACEUTICALS : FDA Approves Regeneron and Sanofi's Dupixent for Ecz..
03/28DJREGENERON PHARMACEUTICALS : FDA Approves Regeneron and Sanofi's Dupixent for Ecz..
03/18DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update
03/17DJAMGEN : Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Staffan Schüberg President & Director
Julie Hakim Secretary, Treasurer & Director
Joseph Nolan Director
Timothy L. Maness Senior Director-Finance & Controller
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CHELSEA THERAPEUTICS I..0.00%0
AMGEN, INC.11.52%120 086
CELGENE CORPORATION7.21%96 538
GILEAD SCIENCES, INC.-6.07%87 925
REGENERON PHARMACEUTIC..7.37%41 811
ACTELION LTD24.44%30 002
More Results